Abbott Laboratories Stock Surges 055% in Two Days Trading Volume Ranks 60th in Market

Abbott Laboratories (ABT) closed at $132.85 on May 30, 2025, marking a 0.55% increase from the previous day's close. This upward trend has continued for two consecutive days, with a total gain of 1.18% over the past two days. The trading volume for the day was 19.00 billion, ranking 60th in the market.

Abbott's recent performance has been bolstered by a 21.6% surge in continuous glucose monitor (CGM) sales, driven by growing global demand for diagnostic tools. However, the company's outlook has been tempered by foreign exchange fluctuations and macroeconomic pressures.

The company's stock is currently valued at a price-to-earnings (P/E) ratio of 17.15, indicating a relatively mature and stable valuation. This suggests that Abbott is a large-cap growth stock in the medical equipment and supplies industry, with a strong fundamental rating.